Vanguard Global Advisers »

Kiora Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Kiora Pharmaceuticals (KPRX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Kiora Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiora Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiora Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $386 200 1.93

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Kiora Pharmaceuticals

ADAR1 Capital Management
Stonepine Capital Management
Citadel Advisors
Geode Capital Management
Vanguard Group
Renaissance Technologies
Vanguard Capital Management
Vanguard Fiduciary Trust
Two Sigma Securities
XTX Topco
Rangeley Capital
Tower Research Capital
Morgan Stanley
UBS Group
SBI Securities

View all funds holding Kiora Pharmaceuticals